Different melanoma TAAs used in melanoma immunotherapy approaches include gp100, MART-1, and three enzymes associated with melanin synthesis, tyrosinase (tyr), tyrosinase related protein-1 and -2 (TRP1 and TRP2). This evidence concerns the gene DCT and melanoma.